Important Updates: COVID-19 vaccinations | Recall on Philips Respironics medical devices

COVID-19: We are vaccinating patients ages 12+. Learn more:

Philips Respironics issued a recall for some CPAP and BiLevel PAP devices and mechanical ventilators. Learn more.

The Newsletter of the Johns Hopkins Department of Psychiatry and Behavioral Sciences

BrainWise Spring 2019

Mining Genes, Data and Human Brains to Assess Mood Disorder Risk

Psychiatry researchers Peter Zandi and Fernando Goes have partnered with the Lieber Institute for Brain Development to study human brain samples and genome data sequencing to identify genetic risk for mood disorders.

Amos Food, Body and Mind Center Tackles Gut-Brain Connection

Gastrointestinal and psychiatric experts are working together to treat patients with complex and connected psychiatric and physical symptoms.
Research Roundup: New Studies on Insomnia, Buprenorphine and More

Learn about the latest developments in dementia care research, chronic pain, and insomnia research and more.
Substance Use Disorders in Older Adults: A Growing Threat

Increasingly, older adults are misusing alcohol and drugs – raising their risks for falls, fractures and other emergencies.

View Archives
View All Publications

Important Updates: COVID-19 vaccinations | Recall on Philips Respironics medical devices

BrainWise Spring 2019

Mining Genes, Data and Human Brains to Assess Mood Disorder Risk

Amos Food, Body and Mind Center Tackles Gut-Brain Connection

Research Roundup: New Studies on Insomnia, Buprenorphine and More

Substance Use Disorders in Older Adults: A Growing Threat